SCHEMBL17675180

SCHEMBL17675180

Cc1c(C(=O)N(C)C)n[nH]c1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPK1 P28482 1/20 0.41
RAB9A P51151 2/20 0.40
HPGD P15428 2/20 0.40
CSNK2A2 P19784 1/20 0.40
KDR P35968 1/20 0.40
CSNK2B P67870 1/20 0.40
CSNK2A1 P68400 1/20 0.40
NPC1 O15118 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
LMNA P02545 1/20 0.39
FLT3 P36888 1/20 0.39
CDC7 O00311 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13539292 0.85 SMN1; SMN2 (0.50) SMN1; SMN2MEN1KMT2AMAPK1RAB9A
SCHEMBL570062 0.83 PIN1 (0.47) SMN1; SMN2MEN1KMT2AMAPK1RAB9A
SCHEMBL24198730 0.78 ALDH1A1 (0.40) SMN1; SMN2MEN1KMT2AMAPK1RAB9A
SCHEMBL6852749 0.76 KDM4E (0.57) SMN1; SMN2MEN1KMT2ARAB9AHPGD
SCHEMBL15554800 0.74 HCAR2 (0.35) NCOA1NCOA3FLT3
SCHEMBL27658275 0.74 HAO2 (0.54) LMNAKDM4E
SCHEMBL20798457 0.72 HCAR2 (0.42) FLT3
SCHEMBL873201 0.70 AKT2 (0.53) SMN1; SMN2MEN1KMT2AMAPK1RAB9A
SCHEMBL4964605 0.70 HAO2 (0.53) LMNA
SCHEMBL16197762 0.70 ALPL (0.46) SMN1; SMN2RAB9ANPC1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 WO disclosed